Biohaven Ltd (NYSE:BHVN)
| 16.53 Delayed Data As of Dec 01 |  +0.71 / +4.49%Today’s Change | 5.54 Today|||52-Week Range 17.39 | -- Year-to-Date |
Latest BHVN News | Press Releases
| Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar? Dec 01 / Zacks.com - Paid Partner Content | How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 54% Nov 28 / Zacks.com - Paid Partner Content |
| After Plunging 13% in 4 Weeks, Here's Why the Trend Might Reverse for Biohaven Ltd. (BHVN) Nov 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.82 |
| Today’s open | 15.90 |
| Day’s range | 15.37 - 16.61 |
| Volume | 401 |
| Average volume (3 months) | 69,833 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 12/01/2022
Growth & Valuation
| Earnings growth (last year) | -80.16% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 29.32 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 1, 2023 |
| EPS forecast (this quarter) | -$1.25 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$213.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
